Urology · Plainview, NY
NPI
1538130802
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
875 Old Country Rd, Suite 301
Plainview, NY, 11803
Phone (516) 931-1710
Groups this clinician bills Medicare through
Medicare paid, 2024
$743K
17,725 services
Medicare patients, 2024
1,485
Average age 77
Drug cost, 2024
$600K
3,596 prescriptions
Company payments, 2025
$815
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey Haberman was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 2,617 times for 1,288 patients. In total Jeffrey Haberman billed 17,725 services in 93 codes, and Medicare paid $743K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,617 | 1,288 | $14.75 | $39K |
| J0897 Injection, denosumab, 1 mg | Office | 1,920 | 12 | $20.50 | $39K |
| 99214 Office E&M - Established | Office | 1,853 | 946 | $114.57 | $212K |
| 81002 Clinical Chemistry | Office | 1,720 | 1,047 | $3.40 | $5,845 |
| 51798 Ultrasound - Nonspecific | Office | 1,283 | 805 | $10.96 | $14K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,134 | 17 | $45.20 | $51K |
| 99213 Office E&M - Established | Office | 1,017 | 718 | $79.77 | $81K |
| 84153 Clinical Chemistry | Office | 475 | 360 | $18.02 | $8,560 |
| 36415 Venipuncture Blood Collection | Office | 397 | 333 | $8.61 | $3,417 |
| 51741 Test - Miscellaneous | Office | 391 | 307 | $11.73 | $4,587 |
| 87086 Bacterial Culture | Office | 390 | 280 | $7.91 | $3,085 |
| 87186 General Laboratory | Office | 314 | 114 | $8.43 | $2,646 |
| 81003 Clinical Chemistry | Office | 292 | 274 | $2.20 | $642 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 284 | 218 | $55.18 | $16K |
| 52000 Cystourethroscopy | Office | 208 | 169 | $231.40 | $48K |
By year: 2022 $601K for 14,410 services; 2023 $694K for 17,163 services; 2024 $743K for 17,725 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,720 | 1,047 | $3.40 | $5,845 |
| 84153 Clinical Chemistry | 475 | 360 | $18.02 | $8,560 |
| 36415 Venipuncture Blood Collection | 397 | 333 | $8.61 | $3,417 |
| 87086 Bacterial Culture | 390 | 280 | $7.91 | $3,085 |
| 87186 General Laboratory | 314 | 114 | $8.43 | $2,646 |
| 81003 Clinical Chemistry | 292 | 274 | $2.20 | $642 |
| 87088 Bacterial Culture | 177 | 114 | $7.93 | $1,404 |
| 87077 Bacterial Culture | 167 | 110 | $7.92 | $1,323 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 48 | 48 | $18.92 | $908 |
| P9612 Catheterization for collection of specimen, single patient, all places of service | 34 | 31 | $8.65 | $294 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey Haberman prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,244 prescriptions and refills. In total Jeffrey Haberman wrote 3,596 Medicare prescriptions that cost $600K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,244 | 3,321 | 376 | $24K |
| Silodosin Generic | 311 | 799 | 109 | $33K |
| Finasteride Generic | 225 | 664 | 61 | $3,993 |
| Methenamine Hippurate Generic | 186 | 432 | 50 | $16K |
| Solifenacin Succinate Generic | 147 | 311 | 51 | $14K |
| Cefuroxime Cefuroxime Axetil | 116 | 116 | 85 | $1,411 |
| Doxazosin Mesylate Generic | 115 | 336 | 32 | $2,248 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 114 | 294 | 33 | $2,012 |
| Dutasteride Generic | 86 | 257 | 23 | $3,792 |
| Myrbetriq Mirabegron | 73 | 143 | 23 | $59K |
| Cephalexin Generic | 69 | 73 | 46 | $1,181 |
| Potassium Citrate Er Potassium Citrate | 69 | 171 | 21 | $9,586 |
| Cefpodoxime Proxetil Generic | 67 | 67 | 42 | $2,658 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 63 | 63 | 40 | $425 |
| Gemtesa Vibegron | 60 | 137 | 17 | $63K |
Brand drugs: 220 claims; generic drugs: 3,376 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey Haberman $815 ($815 in general payments such as food, travel and fees) from 10 companies. The largest payer was Janssen Biotech, Inc. with $239.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 6 | $239 |
| Sumitomo Pharma America, Inc. 4506.T | 8 | $199 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $91.27 |
| Endo USA, Inc. | 4 | $81.86 |
| Pfizer Inc. PFE | 2 | $47.25 |
| Dendreon Pharmaceuticals LLC | 1 | $38.06 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $35.06 |
| Teleflex LLC TFX | 1 | $33.76 |
| Tolmar, Inc. | 1 | $26.8 |
| Accord Healthcare, Inc. | 1 | $23.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.